{
  "cik": 1813814,
  "cik_padded": "0001813814",
  "entityName": "Definium Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-076742",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 257837000.0,
        "eps_diluted": -2.06,
        "net_income": -183793000.0,
        "operating_cash_flow": -131560000.0,
        "operating_income": -166309000.0,
        "stockholders_equity": 332327000.0,
        "total_assets": 440100000.0,
        "total_liabilities": 107773000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.32429805583055243,
        "roa_avg2y": -0.49523139746527794,
        "roa_period_end": -0.41761645080663484,
        "roe_avg2y": -0.6406448520761623,
        "roe_period_end": -0.553048653886082
      }
    },
    {
      "accn": "0001193125-26-076742",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 273741000.0,
        "eps_diluted": -1.54,
        "net_income": -108679000.0,
        "operating_cash_flow": -79129000.0,
        "operating_income": -103916000.0,
        "stockholders_equity": 241448000.0,
        "total_assets": 302151000.0,
        "total_liabilities": 60703000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.25141231238196216,
        "roa_avg2y": -0.5094025667226009,
        "roa_period_end": -0.35968439621248977,
        "roe_avg2y": -0.6801321726505247,
        "roe_period_end": -0.45011348199198165
      }
    },
    {
      "accn": "0001193125-26-076742",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 99704000.0,
        "eps_diluted": -2.44,
        "net_income": -95732000.0,
        "operating_cash_flow": -64365000.0,
        "operating_income": -93866000.0,
        "stockholders_equity": 78134000.0,
        "total_assets": 124541000.0,
        "total_liabilities": 46407000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5939411779762971,
        "roa_avg2y": -0.6500573787746067,
        "roa_period_end": -0.7686785877743073,
        "roe_avg2y": -0.835901174847523,
        "roe_period_end": -1.2252284536821358
      }
    },
    {
      "accn": "0000950170-25-034176",
      "filed": "2025-03-06",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 142142000.0,
        "eps_diluted": -1.84,
        "net_income": -56796000.0,
        "operating_cash_flow": -50139000.0,
        "operating_income": -66331000.0,
        "stockholders_equity": 150917000.0,
        "total_assets": 169993000.0,
        "total_liabilities": 19076000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12640060430567795,
        "roa_avg2y": -0.3401008997140676,
        "roa_period_end": -0.3341078750301483,
        "roe_avg2y": -0.3754102207342827,
        "roe_period_end": -0.37633931233724494
      }
    },
    {
      "accn": "0000950170-24-021656",
      "filed": "2024-02-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 133539000.0,
        "eps_diluted": -3.4,
        "net_income": -93036000.0,
        "operating_cash_flow": -45824000.0,
        "operating_income": -93854000.0,
        "stockholders_equity": 151664000.0,
        "total_assets": 164002000.0,
        "total_liabilities": 12338000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08135088089460914,
        "roa_avg2y": -0.757865925928943,
        "roa_period_end": -0.5672857648077463,
        "roe_avg2y": -0.8177838721586415,
        "roe_period_end": -0.6134349614938285
      }
    },
    {
      "accn": "0000950170-23-007053",
      "filed": "2023-03-09",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 80094000.0,
        "net_income": -33937000.0,
        "operating_cash_flow": -23597000.0,
        "operating_income": -33030000.0,
        "stockholders_equity": 75868000.0,
        "total_assets": 81519000.0,
        "total_liabilities": 5651000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07448463120156061,
        "roa_period_end": -0.4163078546105815,
        "roe_avg2y": -0.8416497197559645,
        "roe_period_end": -0.44731639162756365
      }
    },
    {
      "accn": "0000950170-22-004724",
      "filed": "2022-03-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 4776000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-076742",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2833",
  "sic_description": "Medicinal Chemicals & Botanical Products",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001813814.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001813814.json"
  },
  "ticker": "DFTX"
}